An ambitious ₹18,100 crore scheme to facilitate the manufacture of advanced chemistry cell batteries in India, particularly ...

Allocations for pharmaceuticals, including bulk drugs and medical devices, have remained broadly unchanged at around Rs 2,500 ...

The solar PLI scheme continues to draw strong interest from India’s PV manufacturers, but delivery remains uneven as operational capacity lags awarded commitments. The overall achievement rate stood ...

The government has disbursed INR 21,534 Cr under Production Linked Incentive (PLI) scheme across 12 sectors, including large-scale electronics manufacturing (LSEM), IT hardware, bulk drugs, medical ...

In the revised estimates for FY26, the government expects to spend Rs 2,091.26 crore under the scheme. The allocation for FY24–25 also stood at Rs 2,818.85 crore ...

India’s PLI scheme for high-efficiency solar panels has led to 18.5 GW of PV module manufacturing capacity as of June 30, 2025. It has also added 9.7 GW of solar cell capacity and 2.2 GW of ...

India's ambitious battery manufacturing scheme faces setbacks from visa delays, local production mandates, and technology shortages, report reveals.

India’s PLI scheme has driven investment, output and exports at low fiscal cost by rewarding performance. With simpler design and sharper focus, it can become a core pillar of India’s manufacturing ...

42 companies - including 28 MSMEs and 14 non-MSMEs - have been approved under the scheme.